Example: Heart Attack

Clinical Trials on Adenocarcinoma of the Appendix

Total 234 results

NCT04446091

Recruiting

A Clinical Study of Exploring Camrelizumab in the Treatment of Colorectal Mucinous Adenocarcinoma(MAC)

Conditions: Colorectal Cancer
NCT02130648

Unknown status

Non Ivasive Prenatal Diagnosis (NIPD) of Cystic Fibrosis

Conditions: Noninvasive Mucinous Cystadenocarcinoma of Ovary
NCT01946854

Recruiting

Crossover Trial of Systemic Chemotherapy in Patients With Metastatic Well-Differentiated Mucinous Appendiceal Adenocarcinomas With Pseudomyxoma Peritonei

Conditions: Gastrointestinal Neoplasms
NCT02420509

Terminated

Postoperative Chemotherapy in High-Grade Appendiceal Adenocarcinoma With Peritoneal Carcinomatosis

Conditions: Cancer
NCT01196429

Completed

Temsirolimus, Carboplatin, and Paclitaxel as First-Line Therapy in Treating Patients With Newly Diagnosed Stage III-IV Clear Cell Ovarian Cancer

Conditions: Ovarian Clear Cell Cystadenocarcinoma; Stage III Ovarian Cancer; Stage IV Ovarian Cancer
NCT03976973

Not yet recruiting

Injection of Bromelain and Acetylcysteine in Combination Into Recurrent Mucinous Tumour or Pseudomyxoma Peritonei

Conditions: Pseudomyxoma Peritonei; Peritoneal Cancer; Mucinous Adenocarcinoma; Mucinous Tumor
NCT04633239

Recruiting

Testing the Addition of Abemaciclib to Olaparib for Women With Recurrent Ovarian Cancer

Conditions: Recurrent High Grade Ovarian Serous Adenocarcinoma; Recurrent Platinum-Resistant Ovarian Carcinoma
NCT04507191

Completed

PDL1 in Ovarian High Grade Serous Carcinoma

Conditions: Ovarian Cancer
NCT04284631

Completed

Prognostic Value of Her2neu and EGFR in Primary Ovarian High Grade Serous Carcinoma.

Conditions: Ovarian Cancer
NCT03462342

Recruiting

Combination ATR and PARP Inhibitor (CAPRI) Trial With AZD6738 and Olaparib in Recurrent Ovarian Cancer

Conditions: High Grade Serous Carcinoma
NCT02112552

Terminated

Paclitaxel and Intraperitoneal Carboplatin Followed by Radiation Therapy in Treating Patients With Stage IIIC-IV Uterine Cancer

Conditions: Endometrial Serous Adenocarcinoma; Stage IIIA Uterine Corpus Cancer; Stage IIIB Uterine Corpus Cancer; Stage IIIC1 Uterine Corpus Cancer; Stage IIIC2 Uterine Corpus Cancer; Stage IVA Uterine Corpus Cancer; Stage IVB Uterine Corpus Cancer
NCT01344837

Not yet recruiting

Biomarkers in Blood and Tissue Samples From Patients With Uterine Cancer

Conditions: Endometrial Serous Adenocarcinoma; Stage I Uterine Corpus Cancer; Stage II Uterine Corpus Cancer; Stage III Uterine Corpus Cancer; Stage IV Uterine Corpus Cancer
NCT01525706

Terminated

Endoscopic Ultrasound (EUS) Guided Ethanol With Paclitaxel Ablation for Pancreatic Mucinous Cystic Neoplasm

Conditions: Mucinous Cystic Tumor With Moderate Dysplasia; Mucinous Cystadenoma of Pancreas; Mucinous Cystadenocarcinoma of Pancreas; Benign Neoplasm of Pancreas
NCT01489371

Completed

EGEN-001 and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

Conditions: Ovarian Clear Cell Cystadenocarcinoma; Ovarian Endometrioid Adenocarcinoma; Ovarian Seromucinous Carcinoma; Ovarian Serous Cystadenocarcinoma; Ovarian Undifferentiated Carcinoma; Recurrent Fallopian Tube Carcinoma; Recurrent Ovarian Carcinoma; Recurrent Primary Peritoneal Carcinoma
NCT02059265

Active, not recruiting

Dasatinib in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, Endometrial or Peritoneal Cancer

Conditions: Endometrial Clear Cell Adenocarcinoma; Ovarian Clear Cell Cystadenocarcinoma; Recurrent Fallopian Tube Carcinoma; Recurrent Ovarian Carcinoma; Recurrent Primary Peritoneal Carcinoma; Recurrent Uterine Corpus Cancer
NCT01197664

Terminated

Paricalcitol, Fluorouracil, and Radiation Therapy in Treating Patients With Rectal Cancer That Can Be Removed in Surgery

Conditions: Mucinous Adenocarcinoma of the Rectum; Stage IIA Rectal Cancer; Stage IIB Rectal Cancer; Stage IIC Rectal Cancer; Stage IIIB Rectal Cancer; Stage IIIC Rectal Cancer
NCT01403103

Withdrawn

Cholecalciferol(25-[OH]-Vitamin D) in Treating Patients With Colorectal Cancer

Conditions: Mucinous Adenocarcinoma of the Colon; Mucinous Adenocarcinoma of the Rectum; Signet Ring Adenocarcinoma of the Colon; Signet Ring Adenocarcinoma of the Rectum; Stage I Colon Cancer; Stage I Rectal Cancer
NCT02050009

Withdrawn

Metformin Hydrochloride, Carboplatin, and Paclitaxel in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Conditions: Ovarian Papillary Serous Carcinoma; Ovarian Serous Cystadenocarcinoma; Recurrent Fallopian Tube Cancer; Recurrent Ovarian Epithelial Cancer; Recurrent Ovarian Germ Cell Tumor; Recurrent Primary Peritoneal Cavity Cancer
NCT04814108

Not yet recruiting

A Study of ZN-c3 in Women With Recurrent or Persistent Uterine Serous Carcinoma

Conditions: Uterine Serous Carcinoma
NCT04590248

Recruiting

A Study of Adavosertib as Treatment for Uterine Serous Carcinoma

Conditions: Uterine Serous Carcinoma
NCT04585958

Not yet recruiting

Testing the Combination of DS-8201a and Olaparib in HER2-Expressing Cancers With Expansion in Patients With Endometrial Cancer

Conditions: Endometrial Serous Adenocarcinoma; Metastatic Malignant Solid Neoplasm; Unresectable Malignant Solid Neoplasm
NCT04494113

Not yet recruiting

Testing the Response to the Anti-cancer Drug, Triapine, in Uterine Cancers Using Markers From the Tissue at the Time of Hysterectomy

Conditions: Endometrial Serous Adenocarcinoma
NCT04030000

Not yet recruiting

Uterine Serous Carcinoma and Adjuvant Combined Intraperitoneal Chemotherapy and Radiation

Conditions: Uterine Carcinoma
NCT03794115

Recruiting

Immune Repertoire of Ovarian HGSC

Conditions: Ovarian High Grade Serous Carcinoma; Immune Repertoire; T Lymphocyte Receptor; B Lymphocyte Receptor
NCT03673124

Recruiting

Ribociclib and Letrozole Treatment in Ovarian Cancer

Conditions: Low Grade Serous Carcinoma